US PTO's Patent Eligibility Guidance Draws Industry Plaudits, Request For More Specifics

 
• By Brenda Sandburg

BIO, PhRMA, Novartis, Amgen, and Genentech suggest revisions to guidance on hot-button issue of subject matter patent eligiblity; patent owners group says 'best approach' is to enact legislation to restore patent eligibility law.

3D illustration/ 3D rendering - Subject matter concept
Guidance Helps Clarify How PTO Examiners Should Assess An Invention's Eligibility For Patenting

More from Legal & IP

More from Pink Sheet